RPA49_HUMAN - dbPTM
RPA49_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RPA49_HUMAN
UniProt AC Q9GZS1
Protein Name DNA-directed RNA polymerase I subunit RPA49
Gene Name POLR1E
Organism Homo sapiens (Human).
Sequence Length 481
Subcellular Localization Nucleus, nucleolus .
Protein Description DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase I which synthesizes ribosomal RNA precursors. Appears to be involved in the formation of the initiation complex at the promoter by mediating the interaction between Pol I and UBTF/UBF (By similarity)..
Protein Sequence MYQASAVSLLPRDIPSCHSPSPGFSHLPTSSSQLAPDLLQFPLGQDPSFLAIPILTLPPSDSLVPPYIVWYIVWPSALISFLGCTLTVQFSNGKLQSPGNMRFTLYENKDSTNPRKRNQRILAAETDRLSYVGNNFGTGALKCNTLCRHFVGILNKTSGQMEVYDAELFNMQPLFSDVSVESELALESQTKTYREKMDSCIEAFGTTKQKRALNTRRMNRVGNESLNRAVAKAAETIIDTKGVTALVSDAIHNDLQDDSLYLPPCYDDAAKPEDVYKFEDLLSPAEYEALQSPSEAFRNVTSEEILKMIEENSHCTFVIEALKSLPSDVESRDRQARCIWFLDTLIKFRAHRVVKRKSALGPGVPHIINTKLLKHFTCLTYNNGRLRNLISDSMKAKITAYVIILALHIHDFQIDLTVLQRDLKLSEKRMMEIAKAMRLKISKRRVSVAAGSEEDHKLGTLSLPLPPAQTSDRLAKRRKIT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MYQASAVSL
------CCCCCHHCC
16.8820068231
8 (in isoform 2)Phosphorylation-24.7320068231
8PhosphorylationMYQASAVSLLPRDIP
CCCCCHHCCCCCCCC
24.7320068231
29 (in isoform 2)Phosphorylation-47.8327174698
32 (in isoform 2)Ubiquitination-29.04-
35 (in isoform 2)Phosphorylation-6.4720068231
35PhosphorylationPTSSSQLAPDLLQFP
CCCHHHCCHHHHCCC
6.4723186163
47 (in isoform 2)Ubiquitination-21.06-
80 (in isoform 2)Ubiquitination-18.44-
94AcetylationTVQFSNGKLQSPGNM
EEEEECCEECCCCCE
47.8326051181
97PhosphorylationFSNGKLQSPGNMRFT
EECCEECCCCCEEEE
45.2526055452
102MethylationLQSPGNMRFTLYENK
ECCCCCEEEEEEECC
25.95115488133
104PhosphorylationSPGNMRFTLYENKDS
CCCCEEEEEEECCCC
20.3326074081
106PhosphorylationGNMRFTLYENKDSTN
CCEEEEEEECCCCCC
17.8826074081
109AcetylationRFTLYENKDSTNPRK
EEEEEECCCCCCCCH
40.9126051181
109UbiquitinationRFTLYENKDSTNPRK
EEEEEECCCCCCCCH
40.91-
111PhosphorylationTLYENKDSTNPRKRN
EEEECCCCCCCCHHH
31.5226074081
112PhosphorylationLYENKDSTNPRKRNQ
EEECCCCCCCCHHHH
60.4226074081
126PhosphorylationQRILAAETDRLSYVG
HHHHEEECCHHHHCC
22.9924667141
128MethylationILAAETDRLSYVGNN
HHEEECCHHHHCCCC
32.71115488125
134 (in isoform 2)Ubiquitination-30.52-
138PhosphorylationYVGNNFGTGALKCNT
HCCCCCCCCHHHHHH
18.3628555341
142MethylationNFGTGALKCNTLCRH
CCCCCHHHHHHHHHH
25.5582985949
142UbiquitinationNFGTGALKCNTLCRH
CCCCCHHHHHHHHHH
25.55-
148 (in isoform 2)Ubiquitination-29.41-
163PhosphorylationKTSGQMEVYDAELFN
CCCCCEEEEEHHHHC
4.3821406692
170 (in isoform 2)Ubiquitination-40.5821906983
193PhosphorylationLESQTKTYREKMDSC
HHHCCHHHHHHHHHH
20.5224719451
196AcetylationQTKTYREKMDSCIEA
CCHHHHHHHHHHHHH
38.7226051181
199PhosphorylationTYREKMDSCIEAFGT
HHHHHHHHHHHHHCC
17.3128555341
206PhosphorylationSCIEAFGTTKQKRAL
HHHHHHCCHHHHHHH
25.1124719451
207PhosphorylationCIEAFGTTKQKRALN
HHHHHCCHHHHHHHC
31.68-
225PhosphorylationMNRVGNESLNRAVAK
HHHHCHHHHHHHHHH
34.6423401153
232UbiquitinationSLNRAVAKAAETIID
HHHHHHHHHHHHHHH
41.342190698
232 (in isoform 1)Ubiquitination-41.3421906983
240PhosphorylationAAETIIDTKGVTALV
HHHHHHHCCCHHEEC
21.2024114839
283PhosphorylationYKFEDLLSPAEYEAL
CCHHHHCCHHHHHHH
29.3920873877
287PhosphorylationDLLSPAEYEALQSPS
HHCCHHHHHHHCCHH
14.4928102081
292PhosphorylationAEYEALQSPSEAFRN
HHHHHHCCHHHHHCC
31.1028102081
294PhosphorylationYEALQSPSEAFRNVT
HHHHCCHHHHHCCCC
46.9728102081
309 (in isoform 2)Ubiquitination-6.01-
312 (in isoform 2)Ubiquitination-25.02-
327PhosphorylationEALKSLPSDVESRDR
HHHHCCCCCHHHHHH
60.63-
357MethylationAHRVVKRKSALGPGV
HHHHHHCCCCCCCCC
34.07115975309
358PhosphorylationHRVVKRKSALGPGVP
HHHHHCCCCCCCCCC
32.5325159151
373AcetylationHIINTKLLKHFTCLT
EEECHHHHHHCEEEE
4.2819608861
374AcetylationIINTKLLKHFTCLTY
EECHHHHHHCEEEEE
47.2926051181
385PhosphorylationCLTYNNGRLRNLISD
EEEECCCHHHHHCCH
32.3720068231
390PhosphorylationNGRLRNLISDSMKAK
CCHHHHHCCHHHHHH
4.9920068231
391PhosphorylationGRLRNLISDSMKAKI
CHHHHHCCHHHHHHH
27.1421406692
393PhosphorylationLRNLISDSMKAKITA
HHHHCCHHHHHHHHH
18.5221406692
428AcetylationRDLKLSEKRMMEIAK
HHCCCCHHHHHHHHH
42.077851935
428UbiquitinationRDLKLSEKRMMEIAK
HHCCCCHHHHHHHHH
42.07-
435AcetylationKRMMEIAKAMRLKIS
HHHHHHHHHHHHHHH
48.6719608861
447PhosphorylationKISKRRVSVAAGSEE
HHHCCCEEEECCCCC
12.2920068231
452PhosphorylationRVSVAAGSEEDHKLG
CEEEECCCCCCCCCC
32.8420068231
457AcetylationAGSEEDHKLGTLSLP
CCCCCCCCCCCCCCC
62.0226051181
460PhosphorylationEEDHKLGTLSLPLPP
CCCCCCCCCCCCCCC
24.4921406692
462PhosphorylationDHKLGTLSLPLPPAQ
CCCCCCCCCCCCCCC
27.9821406692
470PhosphorylationLPLPPAQTSDRLAKR
CCCCCCCCHHHHHHH
34.4021406692
471PhosphorylationPLPPAQTSDRLAKRR
CCCCCCCHHHHHHHC
14.5121406692

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RPA49_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
373KAcetylation

24207024

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RPA49_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HNRL1_HUMANHNRNPUL1physical
17353931
DDX20_HUMANDDX20physical
17353931
DDX6_HUMANDDX6physical
17353931
QPCTL_HUMANQPCTLphysical
17353931
RPAC1_HUMANPOLR1Cphysical
17353931
RPAC1_HUMANPOLR1Cphysical
15226435
RPA34_HUMANCD3EAPphysical
15226435
UBF1_HUMANUBTFphysical
15226435
RPA1_HUMANPOLR1Aphysical
15226435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RPA49_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND MASSSPECTROMETRY.

TOP